{"url_path":"/sec/nnvc/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1379006/0001104659-26-061499-index.html","accession_number":"0001104659-26-061499","cik":"0001379006","ticker":"NNVC","issuer_name":"NANOVIRICIDES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1379006/0001104659-26-061499-index.html","primary_entity_key":"0001379006","primary_entity_name":"NANOVIRICIDES, INC."},"word_count":93,"has_tables":true,"body_markdown":"**ITEM 5. OTHER INFORMATION**\n\n**(a) None.**\n\n**(b) Corporate Governance**\n\nDuring the period covered by this Quarterly Report on Form 10-Q, there were no changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors.\n\n**(c) Insider Trading Arrangements and Policies**\n\nDuring the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company “adopted” or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408(a) of Regulation S-K.\n\n​\n\n54\n\n[Table of Contents](#TOC)"}